Skip to main content
SpringerLink
Log in

Vitamin intake and risk of coronary disease: Observation versus intervention

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

The evidence that specific vitamins may be beneficial in the prevention of cardiovascular disease (CVD) is supported by mechanistic models of atherogenesis. We and others have published observational epidemiologic studies in support of vitamins in the primary prevention of CVD, but the results from intervention studies are mixed. This article summarizes the recent results for vitamin E, vitamin D, and the B vitamins, comparing study populations, study designs, and potential methodologic reasons for differences in findings. For vitamin E, observational data suggest benefit at doses of 100 to 400 IU/d. Results from recent large-scale trials are mixed, with some showing modest benefit but others suggesting no benefit, especially for secondary prevention. Results for B vitamins are also mixed and further complicated by the recent folate fortification of the flour supply. If greater B vitamin intake does reduce CVD, the benefits are likely to be greatest for primary prevention and in populations with intake below dietary reference standards. Research on vitamin D and CVD is just beginning to emerge, but current data suggest that if there is benefit it likely needs to be at intake levels much higher than the current reference intakes of 200 to 600 IU/d for American adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Fraunfelder FW: The science and marketing of dietary supplements. Am J Ophthalmol 2005, 140:302–304.

    Article  PubMed  Google Scholar 

  2. US Food and Drug Administration: Dietary supplement enforcement report. Available at http://www.fda.gov/oc/nutritioninitiative/report.html. Accessed May 5, 2007.

  3. Radimer K, Bindewald B, Hughes J, et al.: Dietary supplement use by US adults: data from the National Examination Survey. Am J Epidemiol 2004, 160:339–349.

    Article  PubMed  Google Scholar 

  4. Erwin RB, Wright JD, Reed-Gillette D: Prevalence of Leading Types of Dietary Supplements Used in the Third National Health and Nutrition Examination Survey, 1988–94. Advance Data from Vital and Health Statistics, Number 349. Hyattsville, Maryland: National Center for Health Statistics; 2004.

    Google Scholar 

  5. Rimm EB, Stampfer MJ, Ascherio A, et al.: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993, 328:1450–1456.

    Article  PubMed  CAS  Google Scholar 

  6. Stampfer MJ, Hennekens CH, Manson JE, et al.: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993, 328:1444–1449.

    Article  PubMed  CAS  Google Scholar 

  7. Rimm EB, Willett WC, Hu FB, et al.: Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998, 279:359–364.

    Article  PubMed  CAS  Google Scholar 

  8. Giovannucci E: Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999, 91:317–331.

    Article  PubMed  CAS  Google Scholar 

  9. Giovannucci E, Stampfer MJ, Colditz GA, et al.: Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med 1998, 129:517–524.

    PubMed  CAS  Google Scholar 

  10. He K, Merchant A, Rimm EB, et al.: Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 2004, 35:169–174.

    Article  PubMed  CAS  Google Scholar 

  11. Kushi L H, Fee RM, Sellers TA, et al.: Intake of vitamin A, C, and E and postmenopausal breast cancer. Am J Epidemiol 1996, 144:165–174.

    PubMed  CAS  Google Scholar 

  12. Yusuf S, Dagenais G, Pogue J, et al.: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:154–160.

    Article  PubMed  CAS  Google Scholar 

  13. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567–1577.

    Article  Google Scholar 

  14. The HOPE and HOPE-TOO Trial Investigators: Effects of long-term vitamin E supplementation on cardiovascular events and cancer—a randomized controlled trial. JAMA 2005, 293:1338–1347.

    Article  Google Scholar 

  15. Bonaa K, Njolstad I, Magne-Ueland P, et al.: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578–1588.

    Article  PubMed  CAS  Google Scholar 

  16. Lee IM, Cook NR, Gaziano JM, et al.: Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA 2005, 294:56–65.

    Article  PubMed  CAS  Google Scholar 

  17. Hodis HN, Mack WJ, LaBree L, et al.: Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis. The Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 2002, 106:1453–1459.

    Article  PubMed  CAS  Google Scholar 

  18. Toole JF, Malinow MR, Chambless LE, et al.: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291:565–575.

    Article  PubMed  CAS  Google Scholar 

  19. Bjelakovic G, Nikolova D, Gluud LL: Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA 2007, 297:842–857.

    Article  PubMed  CAS  Google Scholar 

  20. Rothman KJ, Greenland S: Modern Epidemiology. Philadelphia: Lippincott-Raven Publishers; 1998.

    Google Scholar 

  21. Goodman GE, Thornquist MD, Balmes J, et al.: The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004, 96:1742–1750.

    Article  Google Scholar 

  22. Lonn E, Bosch J, Yusuf S, et al.: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338–1347.

    Article  PubMed  Google Scholar 

  23. Waters DD, Alderman EL, Hsia J, et al.: Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in post-menopausal women: a randomized controlled trial. JAMA 2002, 288:2432–2440.

    Article  PubMed  CAS  Google Scholar 

  24. Brown BG, Zhao XQ, Chait A, et al.: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001, 345:1583–1592.

    Article  PubMed  CAS  Google Scholar 

  25. Rapola JM, Virtamo J, Ripatti S, et al.: Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997, 349:1715–1720.

    Article  PubMed  CAS  Google Scholar 

  26. Virtamo J, Rapola JM, Ripatti S, et al.: Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998, 158:668–675.

    Article  PubMed  CAS  Google Scholar 

  27. Stephens NG, Parsons A, Schofield PM, et al.: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347:781–786.

    Article  PubMed  CAS  Google Scholar 

  28. GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447–455.

    Article  Google Scholar 

  29. The Heart Outcomes Prevention Evaluation Study Investigators: Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000, 342:154–160.

    Article  Google Scholar 

  30. Collaborative Group of the Primary Prevention Project: Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001, 357:89–95.

    Article  Google Scholar 

  31. Boaz M, Smetana S, Weinstein T, et al.: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000, 356:1213–1218.

    Article  PubMed  CAS  Google Scholar 

  32. Blot WJ, Li JY, Taylor PR, et al.: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993, 85:1483–1492.

    Article  PubMed  CAS  Google Scholar 

  33. Salonen JT, Nyyssonen K, Salonen R, et al.: Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000, 248:377–386.

    Article  PubMed  CAS  Google Scholar 

  34. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983, 52:223–261.

    Article  PubMed  CAS  Google Scholar 

  35. Steinberg D, Pathasarathy S, Carew TE, et al.: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915–924.

    Article  PubMed  CAS  Google Scholar 

  36. Cook NR, Albert CM, Gaziano JM, et al.: A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women’s Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610–1618.

    Article  PubMed  CAS  Google Scholar 

  37. The Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288:2015–2022.

    Article  Google Scholar 

  38. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202.

    Article  PubMed  Google Scholar 

  39. Jacques PF, Selhub J, Bostom AG, et al.: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340:1449–1454.

    Article  PubMed  CAS  Google Scholar 

  40. Hsia J, Heiss G, Hong R: Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846–854.

    Article  PubMed  CAS  Google Scholar 

  41. B-Vitamin Treatment Trialists’ Collaboration: Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006, 151:282–287.

    Article  CAS  Google Scholar 

  42. Wang X, Qin X, Demirtas H, et al.: Efficacy of folic acid supplmentation in stroke prevention: a meta-analysis. Lancet 2007, 369:1876–1882.

    Article  PubMed  CAS  Google Scholar 

  43. Food and Nutrition Board, Institute of Medicine: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline—a Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients. Washington, DC: The National Academies Press; 2000.

    Google Scholar 

  44. Troen AM, Mitchell B, Sorensen B, et al.: Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 2006, 136:189–194.

    PubMed  CAS  Google Scholar 

  45. Chiuve SE, Giovannucci EL, Hankinson SE, et al.: Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine. Am J Clin Nutr 2005, 82:155–162.

    PubMed  CAS  Google Scholar 

  46. Giovannucci E, Liu Y, Willett WC: Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev 2006, 15:2467–2472.

    Article  PubMed  CAS  Google Scholar 

  47. Giovannucci E, Liu Y, Rimm EB, et al.: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451–459.

    Article  PubMed  CAS  Google Scholar 

  48. Munger KL, Levin LI, Hollis BW, et al.: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832–2838.

    Article  PubMed  CAS  Google Scholar 

  49. Zittermann A, Schleithoff SS, Koerfer R: Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483–492.

    Article  PubMed  CAS  Google Scholar 

  50. Holick MF: The influence of vitamin D on bone health across the life cycle. J Nutr 2005, 135:2739S–2748S.

    PubMed  CAS  Google Scholar 

  51. Zittermann A: Vitamin D and disease prevention with special reference to cardiovascular disease. Progress Biophysics Molecular Biol 2006, 92:39–45.

    Article  CAS  Google Scholar 

  52. Lappe JM, Travers-Gustafson D, Davies KM, et al.: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586–1591.

    PubMed  CAS  Google Scholar 

  53. Chiuve SE, McCullough ML, Sacks FM, Rimm EB: Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 2006, 114:160–167.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA, 02115, USA

    Eric B. Rimm

Authors
  1. Caroline Moats
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric B. Rimm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric B. Rimm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moats, C., Rimm, E.B. Vitamin intake and risk of coronary disease: Observation versus intervention. Curr Atheroscler Rep 9, 508–514 (2007). https://doi.org/10.1007/s11883-007-0068-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-007-0068-6

Keywords

Search

Navigation